Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche Adds Ascidian’s RNA-Writing To Its Neurology Push

Jun 20 2024

• By Andrew McConaghie

RNA

Related Content

Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology

Aug 24 2021

Remix Teams Up With Second Big Pharma With Roche Deal For RNA Technology

Jan 03 2024

Arrakis Inks First Partnership In RNA-Targeted Collaboration With Roche

Apr 08 2020

Related Companies

Roche Holding AG

Ascidian Therapeutics

Arrakis Therapeutics

Remix Therapeutics

Shape Therapeutics, Inc.

Biogen, Inc.

Additional Topics

Deals StartUps and SMEs Gene Therapy Research & Development Commercial Advanced Therapies Neurology BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.